“◐절대적인◑여의나루오피『 YEOTOP1.COM 』 여탑여의나루오피✴여의나루마사지ⅰ여의나루안마❘여의나루풀싸롱✒여의나루스파さ여의나루립카페”的搜索结果，显示 321-330 项，共有 12275 项

1. 肺科- 临床试验- 妙佑医疗国际

   Rochester, Minn. The purpose of this study is to determine whether 2-drug therapy is non-inferior to 3-drug therapy against pulmonary mycobacterium avium ...

2. 神经科- 临床试验- 妙佑医疗国际

   Rochester, Minn. The purpose of this study is to learn more about amyloid and tau burden in the brain of patients with Atypical Alzheimer's Disease and how that ...

3. 神经科- 临床试验- 妙佑医疗国际

   Rochester, Minn. The purpose of this study is to assess the thalamus area of the brain using stereotactic electroencephalography (an EEG with deep electrode ...

4. 神经科- 临床试验- 妙佑医疗国际

   Clinical/cognitive, imaging, biomarker, and genetic characteristics will be assessed across three cohorts: (1) early onset Alzheimer's Disease (EOAD) ...

5. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... 1/2 study in a selected cohort of patient with LM. A Study to Evaluate MRTX849 in Patients with Advanced Solid Tumors with KRAS G12C Mutation. Rochester ...

6. 妙佑医疗国际 - CBD：安全有效？

   处方大麻二酚（CBD）油是一种有效的抗癫痫发作药物。然而，还需开展进一步研究，以确定 CBD 的其他益处和安全性。 CBD 是一种在大麻中发现的化学物质。

7. 神经科- 临床试验- 妙佑医疗国际

   ... (1) reduces recurrent stroke, acute coronary syndrome, and all-cause mortality 6 months after the event, and (2) improves stroke outcomes at 3 months in ...

8. 神经科- 临床试验- 妙佑医疗国际

   ... (1) reduces recurrent stroke, acute coronary syndrome, and all-cause mortality 6 months after the event, and (2) improves stroke outcomes at 3 months in ...

9. 神经科- 临床试验- 妙佑医疗国际

   Cohort 3 includes (1) CMVpp65 absent and (2) CMVpp65 present GBM.. Patients in all subcohorts except 1.11 and 1.12 currently have unresectable advanced or ...

10. 神经科- 临床试验- 妙佑医疗国际

    Clinical/cognitive, imaging, biomarker, and genetic characteristics will be assessed across three cohorts: (1) early onset Alzheimer's Disease (EOAD) ...